ATS 2024 Final Program

Click on the session title to view the speakers

140

MONDAY • MAY 20

BEHAVIORAL • CLINICAL THEMATIC POSTER SESSION

CLINICAL THEMATIC POSTER SESSION

B36 INTERSTITIAL LUNG DISEASE, CYSTIC FIBROSIS, AND SARCOIDOSIS: CLINICAL PERSPECTIVES 9:15 a.m. - 4:15 p.m.

B37 CRITICAL LAB VALUE ALERT!

HORMONES AND ELECTROLYTES IN THE ICU

9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area L (Hall H, Ground Level)

San Diego Convention Center Area K (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1339 DKA/HHS Overlap Syndrome Rare but Deadly When Found P1340 Mind the Gap! Euglycemic Diabetic Ketoacidosis in a Patient Receiving Continuous Renal Replacement Therapy P1341 Navigating the Perfect Storm: A Case of Contrast-Induced Thyroid Storm Leading to Cardiogenic Shock P1342 A Storm is Brewing: A Case of Thyrotoxic Crisis P1343 Unraveling the Enigma: Hyperthyroid State Induced Paralysis P1344 A Rare Presentation of Hashimoto Encephalitis P1345 Acute Onset Paralysis With Profound Hypokalemia: Diagnosis and Management P1346 Lipid Panel: Unveiling the Mystery of an Anion Gap Acidosis P1347 Perplexing Pituitary P1348 Hashimoto’s Encephalopathy: A Rare Cause of Refractory Agitation P1349 Severe Diabetic Ketoacidosis Resulting in Refractory Shock and Stress Cardiomyopathy P1350 Dual Dilemma: Deciphering Severe Hyponatremia Amidst Parotid Cancer and Heart Failure P1351 A Case of Diabetic Ketoacidosis (DKA) Secondary to Olanzapine Use P1352 Salt, Seizures and SIADH: Pituitary (macro)adenoma and Symptomatic Hyponatremia

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1169 Characterizing and Reducing Inappropriate Inhaler Use in a Tertiary Care Interstitial Lung Diseases Clinic P1170 Consequences of Adverse Events Associated With Antifibrotic Medications: Perspectives From People With Idiopathic Pulmonary Fibrosis (IPF) P1171 The Association of Dyspnea and Oxygen Need as Measured by a Graded Treadmill Walk Test in Patients With Idiopathic Pulmonary Fibrosis P1172 Improving Palliative Care Referrals in Progressive Fibrosing Interstitial Lung Diseases P1173 Perspectives on Screening and Early Treatment for Pulmonary Fibrosis P1174 Characteristics of Patients With Interstitial Lung Disease With Progressive Pulmonary Fibrosis in Europe: A Cross-sectional Survey P1175 A Descriptive Analysis of Medical Care in an Interstitial Lung Disease Cohort From a Major Safety Net Health System P1176 Patient Perspectives on Knowledge Gaps in Chronic Hypersensitivity Pneumonitis P1177 Poor Sleep and Fatigue Are Common in Adults With CF Even in the Era of Highly Effective Modulators P1178 Cardiovascular Health in Cystic Fibrosis: Patient Perspectives P1180 Do Socioeconomic Health Disparities Impact Sarcoidosis Disease Severity at Presentation?

ATS 2024 Conference Program • San Diego, CA